ApprovalTrail

Medical device licence · 68135 · Class 3

XPECT CLOSTRIDIUM DIFFICILE TOXIN A/B

Yes: licensed in Canada

Licence status Issued (active); first licensed April 19, 2005. It is in Health Canada’s list of active licences.
Licence number
68135
Licence holder
Remel Inc.Lenexa, KS, United States
Risk class
Class III (moderate to high risk)
Licence type
Test Kit
First licensed
April 19, 2005
Devices covered
1

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • XPECT CLOSTRIDIUM DIFFICILE TOXIN A/B

Recalls and safety alerts that mention it

Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “xpect”. A notice may cover another product or only some lots: read it to see what it covers.

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.